Clinical Trials Browser

Myelodysplastic Syndromes × ibrutinib × Myeloid × Clear all

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT04439006 2023-12-26

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Phase 1 Completed

10 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Hematologic Neoplasms

Clinical Trials

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization